Silencing of Glutathione Peroxidase 3 through DNA Hypermethylation Is Associated with Lymph Node Metastasis in Gastric Carcinomas

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Peng, Dun Fa ^a   Hu, Tian Ling ^a   Schneider, Barbara G ^a   Chen, Zheng ^a,d   Xu, Ze Kuan ^d,e   El Rifai, Wael ^a,b,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^e Jiangsu Province Academy of Clinical Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; GLUTATHIONE PEROXIDASE 3;

ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; DOWN REGULATION; GENE DOSAGE; GENE EXPRESSION REGULATION; GENE LOSS; GENE SILENCING; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; PRIMARY TUMOR; PROMOTER REGION; STOMACH CARCINOGENESIS; STOMACH CARCINOMA;

AZACITIDINE; CASE-CONTROL STUDIES; CELL LINE, TUMOR; DNA METHYLATION; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE SILENCING; GLUTATHIONE PEROXIDASE; HUMANS; LYMPHATIC METASTASIS; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 84867340549     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046214     Document Type: Article

References (34)

1. Parkin DM, Pisani P, Ferlay J, (1999) Estimates of the worldwide incidence of 25 major cancers in 1990. International journal of cancer Journal international du cancer 80: 827-841.
2. Crew KD, Neugut AI, (2006) Epidemiology of gastric cancer. World journal of gastroenterology: WJG 12: 354-362.
3. Pandey R, Misra V, Misra SP, Dwivedi M, Kumar A, et al. (2010) Helicobacter pylori and gastric cancer. Asian Pacific journal of cancer prevention: APJCP 11: 583-588.
4. Piazuelo MB, Epplein M, Correa P, (2010) Gastric cancer: an infectious disease. Infectious disease clinics of North America 24: 853-869, vii.
5. Pritchard DM, Crabtree JE, (2006) Helicobacter pylori and gastric cancer. Current opinion in gastroenterology 22: 620-625.
6. Augusto AC, Miguel F, Mendonca S, Pedrazzoli J Jr, Gurgueira SA, (2007) Oxidative stress expression status associated to Helicobacter pylori virulence in gastric diseases. Clinical biochemistry 40: 615-622.
7. Handa O, Naito Y, Yoshikawa T, (2010) Helicobacter pylori: a ROS-inducing bacterial species in the stomach. Inflammation research: official journal of the European Histamine Research Society [et al] 59: 997-1003.
8. Handa O, Naito Y, Yoshikawa T, (2007) CagA protein of Helicobacter pylori: a hijacker of gastric epithelial cell signaling. Biochemical pharmacology 73: 1697-1702.
9. Smoot DT, Elliott TB, Verspaget HW, Jones D, Allen CR, et al. (2000) Influence of Helicobacter pylori on reactive oxygen-induced gastric epithelial cell injury. Carcinogenesis 21: 2091-2095.
10. Lamb A, Yang XD, Tsang YH, Li JD, Higashi H, et al. (2009) Helicobacter pylori CagA activates NF-kappaB by targeting TAK1 for TRAF6-mediated Lys 63 ubiquitination. EMBO reports 10: 1242-1249.
11. Bagchi D, McGinn TR, Ye X, Bagchi M, Krohn RL, et al. (2002) Helicobacter pylori-induced oxidative stress and DNA damage in a primary culture of human gastric mucosal cells. Digestive diseases and sciences 47: 1405-1412.
12. Papa A, Danese S, Sgambato A, Ardito R, Zannoni G, et al. (2002) Role of Helicobacter pylori CagA+ infection in determining oxidative DNA damage in gastric mucosa. Scandinavian journal of gastroenterology 37: 409-413.
13. Halliwell B, (1999) Antioxidant defence mechanisms: from the beginning to the end (of the beginning). Free radical research 31: 261-272.
14. Strange RC, Spiteri MA, Ramachandran S, Fryer AA, (2001) Glutathione-S-transferase family of enzymes. Mutation research 482: 21-26.
15. Hayes JD, McLellan LI, (1999) Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free radical research 31: 273-300.
16. Brigelius-Flohe R, Kipp A, (2009) Glutathione peroxidases in different stages of carcinogenesis. Biochimica et biophysica acta 1790: 1555-1568.
17. Brigelius-Flohe R, (2006) Glutathione peroxidases and redox-regulated transcription factors. Biological chemistry 387: 1329-1335.
18. Wingler K, Brigelius-Flohe R, (1999) Gastrointestinal glutathione peroxidase. BioFactors 10: 245-249.
19. Herbette S, Roeckel-Drevet P, Drevet JR, (2007) Seleno-independent glutathione peroxidases. More than simple antioxidant scavengers. The FEBS journal 274: 2163-2180.
20. Yoshimura S, Suemizu H, Taniguchi Y, Watanabe K, Nomoto Y, et al. (1991) Molecular cloning of human plasma glutathione peroxidase gene and its expression in the kidney. Nucleic acids symposium series pp. 163-164.
21. Yoshimura S, Suemizu H, Taniguchi Y, Arimori K, Kawabe N, et al. (1994) The human plasma glutathione peroxidase-encoding gene: organization, sequence and localization to chromosome 5q32. Gene 145: 293-297.
22. Takebe G, Yarimizu J, Saito Y, Hayashi T, Nakamura H, et al. (2002) A comparative study on the hydroperoxide and thiol specificity of the glutathione peroxidase family and selenoprotein P. The Journal of biological chemistry 277: 41254-41258.
23. Comhair SA, Erzurum SC, (2005) The regulation and role of extracellular glutathione peroxidase. Antioxidants & redox signaling 7: 72-79.
24. Chen B, Rao X, House MG, Nephew KP, Cullen KJ, et al. (2011) GPx3 promoter hypermethylation is a frequent event in human cancer and is associated with tumorigenesis and chemotherapy response. Cancer letters 309: 37-45.
25. Lee OJ, Schneider-Stock R, McChesney PA, Kuester D, Roessner A, et al. (2005) Hypermethylation and loss of expression of glutathione peroxidase-3 in Barrett's tumorigenesis. Neoplasia 7: 854-861.
26. Yu YP, Yu G, Tseng G, Cieply K, Nelson J, et al. (2007) Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis. Cancer research 67: 8043-8050.
27. El-Rifai W, Moskaluk CA, Abdrabbo MK, Harper J, Yoshida C, et al. (2002) Gastric cancers overexpress S100A calcium-binding proteins. Cancer research 62: 6823-6826.
28. Peng DF, Razvi M, Chen H, Washington K, Roessner A, et al. (2009) DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma. Gut 58: 5-15.
29. Soutto M, Peng D, Razvi M, Ruemmele P, Hartmann A, et al. (2010) Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas. Cancer 116: 4033-4042.
30. Peng D, Belkhiri A, Hu T, Chaturvedi R, Asim M, et al. (2011) Glutathione peroxidase 7 protects against oxidative DNA damage in oesophageal cells. Gut.
31. Liang CC, Park AY, Guan JL, (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nature protocols 2: 329-333.
32. He Y, Wang Y, Li P, Zhu S, Wang J, et al. (2011) Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma. Digestive diseases and sciences 56: 681-688.
33. Jee CD, Kim MA, Jung EJ, Kim J, Kim WH, (2009) Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma. European journal of cancer 45: 1282-1293.
34. Zhang X, Yang JJ, Kim YS, Kim KY, Ahn WS, et al. (2010) An 8-gene signature, including methylated and down-regulated glutathione peroxidase 3, of gastric cancer. International journal of oncology 36: 405-414.